Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
41.25
-1.06 (-2.51%)
At close: Mar 20, 2026, 4:00 PM EDT
42.07
+0.82 (1.99%)
After-hours: Mar 20, 2026, 7:19 PM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $3.24 billion as of March 20, 2026. Its market cap has increased by 162.20% in one year.
Market Cap
3.24B
Enterprise Value
2.48B
1-Year Change
162.20%
Ranking
Category
Stock Price
$41.25
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $3.24B, an increase of 2,800.43%. That is a compound annual growth rate of 40.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.24B | 27.46% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACADIA Pharmaceuticals | 3.54B |
| Dianthus Therapeutics | 3.46B |
| Structure Therapeutics | 3.44B |
| ADMA Biologics | 3.41B |
| NewAmsterdam Pharma Company | 3.33B |
| Legend Biotech | 3.22B |
| Denali Therapeutics | 3.20B |
| Alumis | 3.19B |